Deep Tech Startups

Escape Velocity (EV3) is an early-stage venture investor that writes $500K–$5M checks and partners with founders building frontier technology companies. It focuses on the tokenization of money, data, identity, energy, and intelligence.

1 investor

EVANIUM develops OPTISOLV®, an IP-protected drug-delivery technology that improves the water solubility, stability, absorption, and taste of plant-based active ingredients such as polyphenols and flavonoids. The technology is aimed at brands making food, nutraceutical, pharmaceutical, and personal care products, with development in Germany and production in Europe.

1 investor

Evatronix designs and manufactures eviXscan 3D scanners and develops accompanying 3D scanning software (eviXscan 3D Suite) for industrial and metrology applications. The company offers multiple scanner models, including dual-range and wide-range systems.

1 investor

Daft is a data processing platform that transforms raw multimodal data (video, images, audio, sensor data) into training-ready datasets in a single pipeline. It provides Pandas/Spark-like operations with native support for GPU inference, embeddings, and model serving at scale.

1 investor

Eventum Orthopaedics develops Quadsense, a medical device that provides real-time intraoperative data to surgeons during total knee arthroplasty procedures, helping optimize patellar positioning and patient outcomes. The company also builds Datasense, a data analysis tool for preoperative, intraoperative, and postoperative decision-making in knee surgery.

1 investor

1 investor

Everix manufactures ultra-thin optical filters made from plastic materials for compact and complex optical system designs. The filters serve applications in defense, aerospace, life sciences, and industrial imaging sectors where space constraints, lightweight design, or non-traditional geometries are critical.

1 investor

EVerMed is a company focused on extracellular vesicle biology and pharmaceutical development, combining academic expertise with industry experience in drug development and regenerative medicine.

1 investor

EVerZom is a biotech company developing exosome-based (extracellular vesicle) therapeutics for regenerative medicine, with an innovation platform covering cell sourcing, exosome generation, loading, and formulation. Its pipeline targets digestive tissue healing (Crohn's fistula) and organ regeneration of the liver and kidney.

1 investor

A company that developed a proprietary platform for single-cell immune profiling from small plasma volumes to enable non-invasive diagnostics. Founded from University of Zurich research, it applies immunology and data science to clinical diagnostics.

1 investor

EvolutionaryScale develops artificial intelligence models for biology, including ESM3, a family of models that reason over protein sequence, structure, and function to help scientists understand and design novel proteins. Its models are offered to the scientific community through an API and partner platforms, with a smaller open model available under a non-commercial license.

1 investor

Evolve builds the Human OS Performance Platform, a system that reads real-time brain and body signals and converts them into adaptive training protocols delivered through biosensing, VR mixed reality, and AI closed-loop training. It targets organizations seeking to train and measure human performance, offering individualized programs and performance insights.

1 investor

evoSonic develops hardware and software tools for non-destructive examination (NDE) inspection, serving technicians and asset owners in industries such as oil and gas, manufacturing, and defense. The company builds field-optimized inspection platforms designed to increase productivity, reduce downtime, and improve inspection accuracy.

1 investor

EVSELab provides engineering services for electric vehicle electronics, including full-cycle product development (NPD/ODM), independent verification and validation (Lab-as-a-Service), and reverse engineering. Its core IP includes the Phoenix System, a centralized EV control unit integrating power distribution, communication, and safety logic for automotive applications.

1 investor

ewigbyte develops a long-term data storage technology that writes information as nanostructures onto glass using ultrafast laser pulses, with optical sensors reading the data back. The passive, air-gapped medium is designed to preserve data for century-scale timescales without power, targeting organizations that safeguard critical and sovereign data, with a stated focus on Europe and beyond.

1 investor

Exapto develops engineered biocomponents — novel patented metabolic pathways and enzymes — for industrial biomanufacturing, aimed at improving existing bioproductions and enabling access to chemicals that were previously unreachable from renewable resources. The company combines synthetic biology and AI in its R&D stack to produce key chemicals for the biomanufacturing industry.

1 investor

Exciting Instruments builds the EI-FLEX benchtop platform, a single-molecule fluorescence instrument combining smFRET, FCS and FCCS to measure biomolecular interactions and dynamics directly in solution. It serves academic and industry researchers in life science research, drug development, and clinical diagnostics.

1 investor

Exeger develops and manufactures patented solar cell material that lets everyday products be powered by light, supplying the technology to partners worldwide from its factory in Stockholm. The company works in clean energy and materials, focusing on self-powered consumer products.

1 investor

Exency develops technology that harvests energy from low-grade heat sources and converts it into mechanical work for power generation and cooling applications. The company's net-zero power system is designed as both standalone and integrated solutions across multiple markets.

1 investor

Exia Labs develops simulation and orchestration tools for robotics. The company builds software infrastructure for robotics development.

1 investor

Exo AI builds a foundation model engineered with African languages, dialects, code-switching, and economic realities (mobile money, susu, agent networks, cross-border trade) as its primary training signal. It serves as a platform to power vertical applications across finance, education, commerce, and government for the African continent.

1 investor

ExoInsights builds digital twin technology that provides virtual environments for training, testing, and operational simulation. The platform lets organizations practice and refine processes in a risk-free virtual setting, scale training, and improve operational and employee performance.

1 investor

Exolvo Biosciences develops an oral drug delivery technology using "smart capsules" with dissolvable microneedles for large, complex molecules such as biologics, aiming to replace injections. The company works with pharma and biotech partners and applies technology originally incubated within Verily/Google Life Sciences.

1 investor

Exovolar develops autonomous vertical takeoff and landing (VTOL) air mobility vehicles for individual urban transportation. The company is building compact, single-passenger aircraft with handsfree autonomous capabilities.

1 investor